Related references
Note: Only part of the references are listed.Rare Cause of Infantile Hypercalcemia: A Novel Mutation in the SLC34A1 Gene
Erdal Kurnaz et al.
HORMONE RESEARCH IN PAEDIATRICS (2019)
Novel CYP24A1 Mutation in a Young Male Patient with Nephrolithiasis: Case Report
Jana Jirackova et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2019)
CYP24A1 Variants in Two Chinese Patients with Idiopathic Infantile Hypercalcemia
Yan Sun et al.
FETAL AND PEDIATRIC PATHOLOGY (2019)
Infantile Nephrocalcinosis Resulting From a Pathogenic CYP24A1 Mutation
Joel D. Murphy et al.
KIDNEY INTERNATIONAL REPORTS (2019)
Clinical and molecular characteristics of newly reported mitochondrial disease entity caused by biallelic PARS2 mutations
Elzbieta Ciara et al.
JOURNAL OF HUMAN GENETICS (2018)
CYP24A1 Mutation in a Girl Infant with Idiopathic Infantile Hypercalcemia
Jens Otto Broby Madsen et al.
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY (2018)
Clinical, biochemical, and pathophysiological analysis of SLC34A1 mutations
Amy Fearn et al.
PHYSIOLOGICAL REPORTS (2018)
A Pediatric Patient with a CYP24A1 Mutation: Four Years of Clinical, Biochemical, and Imaging Follow-Up
Diana-Alexandra Ertl et al.
HORMONE RESEARCH IN PAEDIATRICS (2017)
A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass
Pietro Manuel Ferraro et al.
UROLITHIASIS (2017)
Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases
Ewa Pronicka et al.
JOURNAL OF APPLIED GENETICS (2017)
CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations
Colin Patrick Hawkes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Reference intervals for serum 24,25-dihydroxyvitamin D and the ratio with 25-hydroxyvitamin D established using a newly developed LC-MS/MS method
Jonathan C. Y. Tang et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2017)
A Case Report of Compound Heterozygous CYP24A1 Mutations Leading to Nephrolithiasis Successfully Treated with Ketoconazole
Emma Davidson Peiris et al.
CASE REPORTS IN NEPHROLOGY AND DIALYSIS (2017)
Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia
Karl P. Schlingmann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect
D. T. O'Keeffe et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Loss of function of NaPiIIa causes nephrocalcinosis and possibly kidney insufficiency
Dganit Dinour et al.
PEDIATRIC NEPHROLOGY (2016)
Mutational Spectrum of CYP24A1 Gene in a Cohort of Italian Patients with Idiopathic Infantile Hypercalcemia
Maddalena Gigante et al.
NEPHRON (2016)
Kidney Function and Influence of Sunlight Exposure in Patients With Impaired 24-Hydroxylation of Vitamin D Due to CYP24A1 Mutations
Marie-Lucile Figueres et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Calcium and bone homeostasis in heterozygous carrier's of CYP24A1 mutations: A cross-sectional study
M. Cools et al.
BONE (2015)
Maternal and infantile hypercalcemia caused by vitamin-D-hydroxylase mutations and vitamin D intake
Dganit Dinour et al.
PEDIATRIC NEPHROLOGY (2015)
Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole
Judith Sayers et al.
CLINICAL KIDNEY JOURNAL (2015)
A CASE OF LATE-ONSET IDIOPATHIC INFANTILE HYPERCALCEMIA SECONDARY TO MUTATIONS IN THE CYP24A1 GENE
Peter Wolf et al.
ENDOCRINE PRACTICE (2014)
Exome Sequencing Identifies a Novel Homozygous Mutation in the Phosphate Transporter SLC34A1 in Hypophosphatemia and Nephrocalcinosis
Abbhirami Rajagopal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
A Lifetime of Hypercalcemia and Hypercalciuria, Finally Explained
Thomas P. Jacobs et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
CYP24A1 mutation leading to nephrocalcinosis
Frances E. Dowen et al.
KIDNEY INTERNATIONAL (2014)
Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure
Giacomo Colussi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Effective diagnosis of genetic disease by computational phenotype analysis of the disease-associated genome
Tomasz Zemojtel et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis
Galina Nesterova et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene
Filip Fencl et al.
EUROPEAN JOURNAL OF PEDIATRICS (2013)
Lightwood Syndrome Revisited with a Novel Mutation in CYP24 and Vitamin D Supplement Recommendations
Mireille Castanet et al.
JOURNAL OF PEDIATRICS (2013)
Loss-of-Function Mutations of CYP24A1, the Vitamin D 24-Hydroxylase Gene, Cause Long-standing Hypercalciuric Nephrolithiasis and Nephrocalcinosis
Dganit Dinour et al.
JOURNAL OF UROLOGY (2013)
Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation
Edgar Meusburger et al.
CLINICAL KIDNEY JOURNAL (2013)
Hypercalcemia, Hypercalciuria, and Elevated Calcitriol Concentrations with Autosomal Dominant Transmission Due to CYP24A1 Mutations: Effects of Ketoconazole Therapy
Peter J. Tebben et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Genetic Defect in CYP24A1, the Vitamin D 24-Hydroxylase Gene, in a Patient with Severe Infantile Hypercalcemia
Andrew Dauber et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
Mutations in CYP24A1 and Idiopathic Infantile Hypercalcemia
Karl P. Schlingmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Long-term follow-up of patients with idiopathic infantile hypercalcaemia
Jianping Huang et al.
PEDIATRIC NEPHROLOGY (2006)